CRESCENDO PHARMACEUTICALS
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Meditrina Bldg 260 Babraham Research Cam...Phone Number
+44 1223497140Website
www.crescendobiologics.comRevenue
$9.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About CRESCENDO PHARMACEUTICALS
Located in Cambridge, UK, Crescendo Biologics is a clinical stage immuno-oncology company developing novel targeted T cell therapeutics to support cancer patient treatments.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CRESCENDO PHARMACEUTICALS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CRESCENDO PHARMACEUTICALS has new funding data
Check if CRESCENDO PHARMACEUTICALS has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CRESCENDO PHARMACEUTICALS launches new products
Click to see if CRESCENDO PHARMACEUTICALS had a recent Job posting/layoffs
Earning: See what the market has to say on CRESCENDO PHARMACEUTICALS recently announced quarterly report
CRESCENDO PHARMACEUTICALS, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CRESCENDO PHARMACEUTICALS
Website visits: Recent activity has been detected on your website
Check out if CRESCENDO PHARMACEUTICALS is spiking on competitors!
Recommended Actions
Find VP level buyers at CRESCENDO PHARMACEUTICALS
Find 3 more new buyers
Compare Similar Companies to CRESCENDO PHARMACEUTICALS
Compare insights from companies similar to CRESCENDO PHARMACEUTICALS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CRESCENDO PHARMACEUTICALS
$9.1M
11-50
Private
$73.3M
2007
N/A
Company Profile Activity
Activity Insights
CRESCENDO PHARMACEUTICALS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CRESCENDO PHARMACEUTICALS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CRESCENDO PHARMACEUTICALS.
CRESCENDO PHARMACEUTICALS financials insights
Gather financial insights about CRESCENDO PHARMACEUTICALS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$3.3M
2018
Series B
$70M
CRESCENDO PHARMACEUTICALS Tech Stack
A closer look at the technologies used by CRESCENDO PHARMACEUTICALS
Most Recent Scoops
Left Company
Executive Move
New Hire
Executive Move
CRESCENDO PHARMACEUTICALS has announced that Angus Hone has joined the organization as Chief Financial Officer. Previously, Hone served as Interim Chief Financial Officer for Phasor.
Left Company
Executive Move
Funding
CRESCENDO PHARMACEUTICALS News & Media
Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPC
Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307 for patients with mCRPCCrescendo Biologics secures $32M and announces expansion of CB307 ... - Manchester TImes
CAMBRIDGE, England--(BUSINESS WIRE)--Jul 24, 2023--Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces that it plans to augment the ongoing Phase 1b clinical trial of CB307 through the addition of a new pembrolizumab (anti-PD-1) combination expansion cohort. Additional financing of $32 million has been secured with the support of all major existing shareholders, including Sofinnova Partners, Andera Partners, IThe 8 biggest unannounced UK tech fundraises so far this year | Sifted
Most startups want to shout as loud as possible about their latest fundraising deal. But a whole lot of deals also go entirely unannounced.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CRESCENDO PHARMACEUTICALS
Sign Up For FreeTo access detailed company insights
Located in Cambridge, UK, Crescendo Biologics is a clinical stage immuno-oncology company developing novel targeted T cell therapeutics to support cancer patient treatments.... Read More
